| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |